Pliant Therapeutics
PLRX
PLRX
144 hedge funds and large institutions have $1.05B invested in Pliant Therapeutics in 2023 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 143 → 144 (+1)
30% less capital invested
Capital invested by funds: $1.5B → $1.05B (-$443M)
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Holders
144
Holding in Top 10
6
Calls
$7.36M
Puts
$1.86M
Top Buyers
| 1 | +$57.2M | |
| 2 | +$46.7M | |
| 3 | +$16.6M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$16.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$15.7M |
Top Sellers
| 1 | -$38.4M | |
| 2 | -$31.7M | |
| 3 | -$27.2M | |
| 4 |
Jennison Associates
New York
|
-$21.3M |
| 5 |
VA
VR Adviser
New York
|
-$20.7M |